CHOP chemotherapy plus rituximab compared with CHOP alone in diffuse large B-cell lymphoma patients

被引：0
|
作者：
Poddubnaya, I [1 ]
Osmanov, D [1 ]
Babicheva, L [1 ]
Falaleeva, N [1 ]
机构：
[1] NN Blokhin Canc Res Ctr, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
478
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [1] CHOP chemotherapy plus rituximab compared with CHOP alone in patients with diffuse large B-cell lymphoma, from Indian subcontinent.
    Linga, Vijay Gandhi
    Digumarti, Raghunadharao
    Maddi, Rahul Narayan
    Goteke, Vamshi Krishna Reddy
    Gundeti, Sadashivudu
    Thota, Narender Kumar
    Coca, Pragnya
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier, B
    Lepage, E
    Brière, J
    Herbrecht, R
    Tilly, H
    Bouabdallah, R
    Morel, P
    Van den Neste, E
    Salles, G
    Gaulard, P
    Reyes, F
    Gisselbrecht, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04): : 235 - 242
  • [3] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
  • [4] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, T
    Weller, E
    Morrison, V
    Gascoyne, R
    Cassileth, P
    Cohn, J
    Dakhil, S
    Woda, B
    Fisher, R
    Peterson, B
    Horning, S
    ANNALS OF ONCOLOGY, 2005, 16 : 103 - 103
  • [5] CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in patients with singe I diffuse large B-cell lymphoma.
    He, Xiaohui
    Jia, Bo
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Rituximab-CHOP versus CHOP alone in patients with diffuse large B cell lymphoma.
    Cetiner, Mustafa
    Salepci, Taflan
    Atesoglu, Elif Birtas
    Gumus, Mahmut
    Guven, Aslihan
    Undar, Levent
    Tuglular, Tulin Firatli
    Bayik, Mahmut
    BLOOD, 2006, 108 (11) : 259B - 260B
  • [7] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    Current Oncology Reports, 2003, 5 (5) : 357 - 357
  • [8] Impact of the addition of rituximab to initial CHOP chemotherapy compared with CHOP alone in patients with relapsed diffuse large B-cell lymphoma who underwent autologous stem cell transplantation
    Chen, Yi-Bin
    Hochberg, Ephraim P.
    Feng, Yang
    Motyckova, Gabriela
    Neuberg, Donna
    Spitzer, Thomas R.
    Fisher, David C.
    LaCasce, Ann S.
    BLOOD, 2007, 110 (11) : 362B - 363B
  • [9] Rituximab and Bendamustin in patients with diffuse large B-cell lymphoma not eligible for CHOP like chemotherapy
    Kuntz, E.
    Schmitt, T.
    Dietrich, S.
    Bonn, S.
    Ho, A. D.
    Witzens-Harig, M.
    ONKOLOGIE, 2010, 33 : 47 - 47
  • [10] PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)
    Go, S. I.
    Park, M. J.
    Kim, H. G.
    Kang, M. H.
    Lee, G. W.
    HAEMATOLOGICA, 2016, 101 : 686 - 687
12345